FIELD: medicine; treatment of neurodegenerative diseases, in particular Alzheimer's disease. SUBSTANCE: it is recommended to use hydrogenated pyrido (4,3-6) indoles of general formula 1 , in which R1, R2, R3 are as defined in specification. These compounds are NMDA antagonists and are useful in treating neurodegenerative diseases, in particular, Alzheimer's disease. Invention reports results of examination of patients affected with Alzheimer's disease before and after administration of DIMEBON, one of compounds covered by general formula 1. EFFECT: improved results in treatment of difficult-to-treat Alzheimer's disease. 36 tbl
Authors
Dates
1998-03-20—Published
1995-10-23—Filed